Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Pluri Inc. - SIC # 6794 - PATENT OWNERS AND LESSORS
Ticker
Exchange
SIC #
Website
Latest Ticker
PLUR
Nasdaq
6794
www.pluri-biotech.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Pluri Inc.
Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing
- Jun 2nd, 2026 5:30 am
Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest In
- May 30th, 2026 9:46 am
Pluri Insider Ups Holding During Year
- May 28th, 2026 4:56 am
EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug
- May 1st, 2026 2:00 pm
Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement
- Mar 26th, 2026 6:30 am
Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent
- Feb 18th, 2026 6:00 am
Pluri: Fiscal Q2 Earnings Snapshot
- Feb 12th, 2026 3:12 pm
Pluri showcases cell expansion platform as Resbiomed program advances
- Feb 9th, 2026 8:30 am
Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials
- Jan 22nd, 2026 7:15 am
Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved
- Dec 22nd, 2025 5:00 am
A US$3.4m Market Cap Boost Pleasing ToPluri Insiders
- Dec 19th, 2025 3:38 am
Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic Shift and Unlock Value, Backed by Additional Investment
- Dec 9th, 2025 6:30 am
Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgriculture Company of the Year
- Nov 13th, 2025 6:00 am
Pluri: Fiscal Q1 Earnings Snapshot
- Nov 12th, 2025 2:55 pm
Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare
- Nov 11th, 2025 6:00 am
Leading Global Players Back and Fund Pluri’s Cell-Based Food and Agriculture Collaborations
- Nov 10th, 2025 6:00 am
Pluri Subsidiary Coffeesai Partners with Mexico’s INCAFECH to Advance Cell-Based Coffee Manufacturing
- Oct 24th, 2025 6:07 am
Pluri Subsidiary Coffeesai and Instituto del Café de Chiapas Announce Strategic Collaboration to Advance Cell-Based Coffee Manufacturing in Mexico
- Oct 8th, 2025 7:00 am
Scroll